Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport

Abstract

Marked differences can be detected in the intracellular accumulation of HIV PI drugs in vitro. Both P-glycoprotein and MRP1 may play a role in limiting the intracellular concentration of the PI and active influx mechanisms may contribute to drug accumulation.